San Francisco Public Press (https://www.sfpublicpress.org/category/hiv-aids/)
It seems that we’ve pushed the COVID-19 pandemic into the collective “memory hole” — a place where those thoughts, feelings and traumas can be dropped, comfortably out of sight. But remembering is vital to processing grief and readying countermeasures for a future outbreak.
Over the past several months, health care providers have been warning San Francisco officials that while the city was focused on fighting COVID-19, rates of HIV infection and related illnesses were creeping in the wrong direction.
From the very beginning, and throughout the HIV epidemic, which began in 1981, San Francisco led the way in prevention, care and treatment that came to be recognized around the world.
The Bay Area Reporter distributed its first edition on April 1, 1971. While publisher Bob Aaron Ross may have chosen April Fool’s Day as a light-hearted start for the gay community’s latest bar “rag,” the newspaper would go on to do serious journalism, covering the major events of the post-Stonewall era.
AIDS2020: Virtual, the biannual conference of the International AIDS Society, held in early July, marked a turning point for long-term HIV/AIDS survivors — and not a good one. Five of us in San Francisco who have been on the front lines of the fight for our LGBTQ and HIV communities from the very beginning, left the event feeling sidelined and fed up. So, we met to discuss the myriad issues confronted by us long-term survivors. The result: The San Francisco Principles 2020, which we hope will be the seed for a new movement.
Like most of the homeless residents on Willow Street Tuesday morning, Leif Skorochod was headed for either a city-sanctioned tent camp or the barracks-style homeless shelter at Moscone Convention Center after city workers arrived early that morning and gave them a choice: Accept shelter or leave. Homeless Outreach Team members discussed placement options with tent residents while Public Works crews tossed items into truck beds. At least two residents received hotel rooms because they have underlying health conditions. The rest of those the Public Press spoke to were either headed to Moscone or a sanctioned camp site.
“History doesn’t repeat itself, but it does rhyme.” While the remark may or may not have been made by Mark Twain, it certainly rings true as we compare the 1980s with 2020, when an incompetent response to a pandemic and a minority’s call for justice brought people to the streets.
UPDATE: How antimalarial drugs could be used
Scientists at Gladstone Institutes are using techniques developed in AIDS research to understand the life cycle of the coronavirus that causes COVID-19.
Foster City drugmaker Gilead recently updated its application with the federal Food and Drug Administration for approval to market its HIV treatment medication Truvada as an HIV prevention pill. If the FDA approves Truvada for preventive use, it “would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex,” according to a company statement at the time of the filing in December 2011.
Group archives, displays works of hundreds from Bay Area
To help artists who were suffering from life-threatening illnesses, a collective of artists, art collectors and gallery owners began convening at local art spaces in the city in late 1980s. Their mission was to find a means to record the existing works of artists with AIDS and provide them with the materials they needed to create new ones. The group grew into a fullfledged nonprofit called Visual Aid in 1989, and the organization has been supporting hundreds of Bay Area artists since then.
As overall AIDS rates fall in Alameda County, the rate in the black community has hardly budged in the past 10 years, making African Americans in this part of the East Bay increasingly overrepresented among sufferers of the disease.
Read more…
A new report concerning the health of boys of different ethnicities focuses on the effect of neighborhoods and communities on physical and mental health.
Read more…
